Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers LWR Fong, DC Yang, CH Chen Cancer and Metastasis Reviews 36, 737-747, 2017 | 67 | 2017 |
Cigarette smoking-mediated macrophage reprogramming: mechanistic insights and therapeutic implications DC Yang, CH Chen Journal of nature and science 4 (11), 2018 | 49 | 2018 |
MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer J Liu, SJ Chen, SW Hsu, J Zhang, JM Li, DC Yang, S Gu, KE Pinkerton, ... Theranostics 11 (9), 4122, 2021 | 39 | 2021 |
Potential new therapeutic approaches for renal cell carcinoma DC Yang, CH Chen Seminars in nephrology 40 (1), 86-97, 2020 | 39 | 2020 |
Metabolic reprogramming: A driver of cigarette smoke-induced inflammatory lung diseases L Li, DC Yang, CH Chen Free Radical Biology and Medicine 163, 392-401, 2021 | 28 | 2021 |
Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis JM Li, DC Yang, J Oldham, A Linderholm, J Zhang, J Liu, NJ Kenyon, ... Molecular Therapy 29 (4), 1487-1500, 2021 | 23 | 2021 |
Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression DC Yang, JM Li, J Xu, J Oldham, SH Phan, JA Last, R Wu, CH Chen The FASEB Journal 33 (12), 14354, 2019 | 18 | 2019 |
Targeting the AXL receptor in combating smoking-related pulmonary fibrosis DC Yang, S Gu, JM Li, SW Hsu, SJ Chen, WH Chang, CH Chen American journal of respiratory cell and molecular biology 64 (6), 734-746, 2021 | 17 | 2021 |
Cigarette smoke regulates the competitive interactions between NRF2 and BACH1 for heme oxygenase-1 induction WH Chang, P Thai, J Xu, DC Yang, R Wu, CH Chen International journal of molecular sciences 18 (11), 2386, 2017 | 17 | 2017 |
A novel renoprotective strategy: upregulation of PD-L1 mitigates cisplatin-induced acute kidney injury J Liu, DC Yang, J Zhang, SW Hsu, RH Weiss, CH Chen International Journal of Molecular Sciences 22 (24), 13304, 2021 | 5 | 2021 |
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis JM Li, WH Chang, L Li, DC Yang, SW Hsu, NJ Kenyon, CH Chen Respiratory Research 24 (1), 132, 2023 | 4 | 2023 |
MTAP deficiency contributes to immune landscape remodelling and tumour evasion WH Chang, SW Hsu, J Zhang, JM Li, DD Yang, CW Chu, EE Yoo, ... Immunology 168 (2), 331-345, 2023 | 4 | 2023 |
Single‐Cell Spatial Transcriptomics Unveils Platelet‐Fueled Cycling Macrophages for Kidney Fibrosis J Liu, B Zheng, Q Cui, Y Zhu, L Chu, Z Geng, Y Mao, L Wan, X Cao, ... Advanced Science, 2308505, 2024 | 1 | 2024 |
Upregulation of MARCKS in Macrophage Reprogramming and Its Potential as a Therapeutic Target for Pulmonary Fibrosis SY Chang, WH Chang, A Linderholm, DC Yang, SA Liu, SW Hsu, ... B29. BIOMARKERS AND NEW THERAPEUTICS TARGETS IN LUNG FIBROSIS, A3236-A3236, 2024 | | 2024 |
Tobacco Smoke Rewires Immune Microenvironment and Activates Macrophages to Promote Pulmonary Fibrosis WH Chang, SY Chang, A Linderholm, SW Hsu, DC Yang, I Wu, ... B15. THE MACROPHAGE IN ALL ITS GLORY, A3003-A3003, 2024 | | 2024 |
Spatial Decoding of Immune Cell Contribution to Fibroblastic Foci in Idiopathic Pulmonary Fibrosis DC Yang, SW Hsu, JM Li, J Oldham, CH Chen American Journal of Respiratory and Critical Care Medicine 208 (6), 728-731, 2023 | | 2023 |
Novel Dual Action Peptide Therapeutic in Attenuation of Pulmonary Fibrosis DC Yang, L Franzi, SW Hsu, CH Chen, R Wu C28. FROM OMICS TO EX VIVO MODELS: A ROAD MAP FOR NOVEL THERAPIES IN LUNG …, 2023 | | 2023 |
Mps modified peptides and use thereof R Wu, CH Chen, DC Yang US Patent App. 17/611,511, 2022 | | 2022 |
Tobacco smoke activated fibrogenic MARCKS/AXL complex promotes macrophage reprogramming and pulmonary fibrosis DC Yang, J Zhang, JM Li, CW Chu, SW Hsu, CH Chen The Journal of Immunology 208 (1_Supplement), 48.04-48.04, 2022 | | 2022 |
A Novel Function of Inositol in Reducing Pulmonary Fibrosis Progression L Li, JM Li, DC Yang, A Linderholm, L Franzi, SW Hsu, CH Chen A60. PULMONARY FIBROSIS: ANIMAL AND CELL CULTURE MODELS, A1927-A1927, 2022 | | 2022 |